|
|
|
|
|
Salcitonin Acetate |
|
C145H240N44O48S2 |
|
47931-85-1 |
|
It is clinically used to treat senile osteoporosis, post-menopause osteoporosis, fracture, deformed osteitis, neurogenic and dystrophic diseases, and hypercalcemia induced by metastatic tumor of bone. |
|
Parameters of Product: 1 .Appearance :White powder 2 .Water Content(Karl Fischer) :¡Â6.0% 3 .Acetate Content(by HPLC) :¡Â13.0% 4 .Amino Acid Composition :¡¾10% of theoretical 5 .Purity (by HPLC) :¡Ã98.0% 6 .Single Impurity(by HPLC) :¡Â1.0% 7 .Peptide Content(by %N) :¡Ã80% 8 .Assay(By Anhydrous, Acetic Acid-free ) :95.0~105.0% 9 .Bacterial Endotoxins :¡Â5EU/mg
|
Industrial field |
pharmaceutical |
|
|
|
|
|
|
|
There are no existing companies to distribute selected chemical product |
|
|
|
|
|